Pretzel Therapeutics Stock
Pretzel Therapeutics is a biotech company developing first‑in‑class small molecule treatments that restore mitochondrial function by activating enzymes critical to mitochondrial DNA maintenance. It employs a proprietary energetics‑focused platform to modulate bioenergetic pathways across a wide spectrum of neurological, metabolic, muscle‑wasting, and rare diseases, aiming to improve cellular survival and function by correcting energy regulation.
Sign up for SecondMarket® to view the market and buy or sell Pretzel Therapeutics Stock
Buy + SellPretzel Therapeutics Funding
Sign up to gain insights into Pretzel Therapeutics funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series B | Aug 09, 2024 | 59.25M | ||
| Series A | Sep 12, 2022 | 73.45M |
See Pretzel Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Pretzel Therapeutics Stock Valuation + Share Prices
View real-time Tape D® data on Pretzel Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Pretzel Therapeutics Management Team
-
CEO, Board Member
Jay Parrish
-
Co-Founder
Maria Falkenberg
-
COO
Baruch Harris
-
Co-Founder
Claes Gustafsson
-
Co-Founder
Michal Minczuk
-
Co-Founder
Nils-Göran Larsson
-
Co-Founder, Chief Scientific Officer
Gabriel Martinez
Pretzel Therapeutics Major Investors
-
Karolinska Institutet Holding
-
HealthCap Partners
-
Angelini Ventures
-
Cambridge Enterprise
-
Mito Funds
-
Invus Group
-
Cambridge Innovation Capital (CIC)
-
Mubadala Capital
-
Google Ventures
-
ARCH Venture Partners
-
GU Ventures
-
Eir Ventures
Learn More About Pretzel Therapeutics Stock
Buy Pretzel Therapeutics Stock
01Pretzel Therapeutics stock does not trade on public stock exchanges. Pretzel Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Pretzel Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Pretzel Therapeutics Stock
02Pretzel Therapeutics Stock does not trade on public stock exchanges. In order to sell Pretzel Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Pretzel Therapeutics Stock Price
03Pretzel Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Pretzel Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Pretzel Therapeutics Stock Ticker Symbol
04There is no ticker symbol for Pretzel Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Pretzel Therapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Pretzel Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Pretzel Therapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Pretzel Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Pretzel Therapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Pretzel Therapeutics IPO
08Pretzel Therapeutics is a private company and has not had an IPO. There is currently no Pretzel Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Pretzel Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Pretzel Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
